Viewing nowBeoba Tablet 50 mg (Bevagron)
Vibegron 50mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 202203951 · Approved 2022.10.31
Treatment of symptoms of overactive bladder (urinary urgency, frequent urination, etc.)
This medication is used to treat the symptoms of urgency, frequency, and urge incontinence caused by overactive bladder. These symptoms can cause significant discomfort in daily life, and this medication can effectively improve them. Patients can expect relief from urinary-related symptoms by taking this medication regularly. Overall, it is a therapeutic agent that helps improve quality of life.
Adults: Administer 50mg of vibegron orally once daily after a meal
This medication should not be used by patients who are allergic to this medication or any of its components. Additionally, this medication contains lactose and should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with severe heart disease should use this medication cautiously, as there is a risk of increased heart rate worsening symptoms. Patients with reduced liver or kidney function may need to be cautious as the blood concentration of this medication may increase. Patients with prolonged QT interval or bladder outlet obstruction should also use this medication carefully. During the use of this medication, side effects such as constipation and dry mouth may occur, and symptoms such as headache, dizziness, insomnia, dyspepsia, and urinary difficulty have also been reported. Particularly, urinary retention symptoms, where urination is difficult, may occur; if this happens, immediate consultation with a physician is necessary. Before using this medication, thorough examination and questioning are needed to rule out other conditions that may cause similar symptoms. Moreover, this medication may interact with drugs related to specific liver enzymes, so it is essential to consult with a physician or pharmacist about other medications being taken. Women who are pregnant or may become pregnant should carefully consider the benefits and risks before using this medication, and nursing mothers should also consult a specialist. Safety and efficacy in pediatric patients have not yet been established, thus use is not recommended. Elderly patients should be closely monitored as they generally have decreased physical function while taking this medication. In cases of overdose, monitoring pulse, blood pressure, electrocardiogram, etc., is necessary, and appropriate treatment according to symptoms is required. Finally, this medication should be kept out of reach of children, and it is advisable not to transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air or humidity. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.
Pale green round film-coated tablet
30 tablets/box [10 tablets/Alu-Alu X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.